Hélène Trebeden‐Negre

Phase I Trial of Autologous CAR T Cells Targeting NKG2D Ligands in Patients with AML/MDS and Multiple Myeloma

Susanne H.C. Baumeister, Joana Murad, Lillian Werner et al. · Cancer Immunology Research · 2018 · 325 citations · Full text

Pharmacy, Immunology, Oncology +17

G-CSF mobilizes CD34 ⁺ regulatory monocytes that inhibit graft-versus-host disease

Maud D’Aveni, Julien Rossignol, Téreza Coman et al. · Science Translational Medicine · 2015 · 84 citations

Life Sciences, Cell Biology, Immunology +16

Successful hematopoietic stem cell mobilization and apheresis collection using plerixafor alone in sickle cell patients

Erica B. Esrick, John Manis, Heather Daley et al. · Blood Advances · 2018 · 81 citations · Full text

Medicine, Hematology, Cell Therapy +14

Preclinical Evaluation of a Novel Lentiviral Vector Driving Lineage-Specific BCL11A Knockdown for Sickle Cell Gene Therapy

Christian Brendel, Olivier Nègre, Michael Rothe et al. · Molecular Therapy — Methods & Clinical Development · 2020 · 68 citations · Full text

Life Sciences, Genetics, Molecular Biology +15

Pre-transplant donor CD4− invariant NKT cell expansion capacity predicts the occurrence of acute graft-versus-host disease

M-T Rubio, Marie Bouillié, Naïm Bouazza et al. · Leukemia · 2016 · 56 citations · Full text

Life Sciences, Immunology, Clinical Immunology +11